Moreover, DENND2D is a candidate tumor suppressor gene that is regulated by silencing via promoter hypermethylation; DENND2D also serves as a novel biomarker for the early recurrence of HCC, ESCC and GC. Here, DENND2D is linked to esophageal squamous cell carcinoma.